Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2001-6-1
pubmed:abstractText
To prospectively evaluate the effectiveness, safety, and clinical benefits of once-weekly epoetin alfa therapy as an adjunct to chemotherapy in anemic cancer patients.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2875-82
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:11387360-Activities of Daily Living, pubmed-meshheading:11387360-Adolescent, pubmed-meshheading:11387360-Adult, pubmed-meshheading:11387360-Aged, pubmed-meshheading:11387360-Aged, 80 and over, pubmed-meshheading:11387360-Anemia, pubmed-meshheading:11387360-Antineoplastic Agents, pubmed-meshheading:11387360-Blood Transfusion, pubmed-meshheading:11387360-Drug Administration Schedule, pubmed-meshheading:11387360-Erythropoietin, pubmed-meshheading:11387360-Fatigue, pubmed-meshheading:11387360-Female, pubmed-meshheading:11387360-Hematinics, pubmed-meshheading:11387360-Hemoglobins, pubmed-meshheading:11387360-Humans, pubmed-meshheading:11387360-Injections, Subcutaneous, pubmed-meshheading:11387360-Male, pubmed-meshheading:11387360-Middle Aged, pubmed-meshheading:11387360-Neoplasms, pubmed-meshheading:11387360-Prospective Studies, pubmed-meshheading:11387360-Quality of Life, pubmed-meshheading:11387360-Recombinant Proteins, pubmed-meshheading:11387360-Treatment Outcome
pubmed:year
2001
pubmed:articleTitle
Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.
pubmed:affiliation
Mount Sinai Medical Center, New York, NY 10029, USA. janice.gabrilove@mssm.edu
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study